1834 Investment Advisors’s Medpace MEDP Stock Holding History

1834 Investment Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-60	Closed	-$6K	–	450
2020 Q2	$6K	Buy	+60	New	+$5.11K	﹤0.01%	363

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

1834 Investment Advisors's MEDP Position: Q3 2020 in Review

1834 Investment Advisors sold out of Medpace (MEDP) in Q3 2020, closing a stake of 60 shares — an estimated $6K sold.

1834 Investment Advisors first reported a position in MEDP in Q2 2020 and held it in 1 quarter. The position peaked at $6K in Q2 2020. 310 funds tracked by Wall St. Rank hold MEDP as of Q3 2020.

1834 Investment Advisors reported no remaining Medpace position as of Q3 2020 after selling out during the quarter.
1834 Investment Advisors sold 60 Medpace shares in Q3 2020, an estimated $6K.
1834 Investment Advisors first reported a position in Medpace in Q2 2020 and held it in 1 quarter.
1834 Investment Advisors's Medpace position peaked at $6K in Q2 2020.
310 funds tracked by Wall St. Rank held Medpace as of Q3 2020.

Based on 1834 Investment Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.